Gene therapy based precision medicine therapeutics: Clinical pharmacology & translational science considerations Blog Gene therapy based precision medicine therapeutics: Clinical pharmacology & translational science considerations The era of gene therapy may have started a couple of decades ago, but approvals…Certara2021 年 8 月 13 日
生物制剂的临床药理计划是怎样的? 网络研讨会点播 生物制剂的临床药理计划是怎样的? Monoclonal antibodies are now widely used in the treatment of several diseases, providing effective and…Certara2021 年 8 月 6 日
Succeeding in value communication: Introduction Blog 价值沟通制胜之道:导言 Drawn from the experiences of the BaseCase Consulting Team, this is the introduction to ‘Succeeding…Certara2021 年 8 月 5 日
Application of Quantitative Systems Pharmacology to guide the optimal dosing of COVID-19 vaccines Publication 应用定量系统药理学(QSP)指导 COVID-19 疫苗最佳剂量方案 Optimal use and distribution of coronavirus disease 2019 (COVID-19) vaccines involves adjustments of dosing. Due…Certara2021 年 7 月 31 日
PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking On-Demand Webinar PBPK Modeling of Tizanidine Systemic Exposure by CYP1A2 Modulation: Impact of DDIs & Smoking This webinar was presented on 2021 年 6 月 30 日 by David R. Taft, Ph.D. Professor, Pharmaceutics,…Certara2021 年 7 月 26 日
What is BaseCase? 视频 What is BaseCase? Developing interactive and easy-to-use stakeholder engagement content market access, medical affairs, and sales field teams…Certara2021 年 7 月 20 日
Open-Source Modeling Tools: Fueling the Fire vs. Extinguishing the Debate On-Demand Webinar 开源建模工具:火上浇油 vs. 平息争论 The paper “Opening a Debate on Open-Source Modelling Tools: Pouring Fuel on Fire vs. Extinguishing…Certara2021 年 7 月 15 日
Key considerations to ensure maximal probability of antibody drug conjugate development success Blog 确保抗体-药物偶联物开发最大概率获得成功的关键考虑事项 Antibody drug conjugates (ADC) are a unique way to obliterate tumor cells and represent an…Certara2021 年 7 月 8 日
Meet a Certara regulatory operations specialist Video 会见 Certara 监管运营专家 Meet Rachel Bombara, Sr. Regulatory Operations Specialist at Certara. In this brief video Rachel shares…Certara2021 年 7 月 2 日
Maximizing oligonucleotide therapeutic development: Pre-clinical and translational considerations Blog Maximizing oligonucleotide therapeutic development: Pre-clinical and translational considerations This is the second of three blog posts discussing best practices for developing oligonucleotide therapeutics.…Certara2021 年 6 月 25 日